PB
TAK icon

Pinnacle Bancorp’s Takeda Pharmaceutical TAK Stock Holding History

Pinnacle Bancorp’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$57.4K Buy
3,583
+2,388
+200% +$39.5K 0.01% 439
2026
Q1 		$22.1K Hold
1,195
– – 0.01% 585
2025
Q4 		$18.6K Hold
1,195
– – 0.01% 603
2025
Q3 		$17.5K Hold
1,195
– – 0.01% 642
2025
Q2 		$18.5K Hold
1,195
– – 0.01% 612
2025
Q1 		$17.8K Hold
1,195
– – 0.01% 604
2024
Q4 		$15.8K Sell
1,195
-626
-34% -$8.6K 0.01% 621
2024
Q3 		$25.9K Hold
1,821
– – 0.01% 522
2024
Q2 		$23.6K Hold
1,821
– – 0.01% 524
2024
Q1 		$25.3K Buy
1,821
+207
+13% +$3.01K 0.01% 512
2023
Q4 		$23K Sell
1,614
-425
-21% -$6.03K 0.01% 510
2023
Q3 		$31.5K Hold
2,039
– – 0.01% 439
2023
Q2 		$32K Hold
2,039
– – 0.01% 441
2023
Q1 		$33.6K Hold
2,039
– – 0.01% 420
2022
Q4 		$32K Buy
2,039
+457
+29% +$6.38K 0.01% 408
2022
Q3 		$21K Hold
1,582
– – 0.01% 450
2022
Q2 		$22K Sell
1,582
-300
-16% -$4.28K 0.01% 437
2022
Q1 		$27K Hold
1,882
– – 0.01% 430
2021
Q4 		$26K Sell
1,882
-785
-29% -$11K 0.01% 436
2021
Q3 		$44K Sell
2,667
-69
-3% -$1.16K 0.02% 363
2021
Q2 		$46K Buy
2,736
+209
+8% +$3.56K 0.02% 365
2021
Q1 		$46K Buy
2,527
+1,601
+173% +$28.8K 0.02% 358
2020
Q4 		$17K Hold
926
– – 0.01% 484
2020
Q3 		$17K Hold
926
– – 0.01% 460
2020
Q2 		$17K Hold
926
– – 0.01% 452
2020
Q1 		$14K Sell
926
-220
-19% -$3.99K 0.01% 444
2019
Q4 		$23K Hold
1,146
– – 0.02% 417
2019
Q3 		$20K Hold
1,146
– – 0.01% 446
2019
Q2 		$20K Hold
1,146
– – 0.01% 442
2019
Q1 		$23K Buy
+1,146
New +$23.1K 0.01% 416

Other funds holding TAK

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

Pinnacle Bancorp's TAK Position: Q2 2026 in Review

Pinnacle Bancorp increased its Takeda Pharmaceutical (TAK) stake by 200% in Q2 2026, buying an estimated $39.5K and bringing the position to 3,583 shares worth $57.4K. The position accounts for 0.01% of the portfolio, ranked #439.

Pinnacle Bancorp first reported a position in TAK in Q1 2019 and has held it in 30 quarters since. 376 funds tracked by Wall St. Rank hold TAK as of Q2 2026.

  • Pinnacle Bancorp held 3,583 shares of Takeda Pharmaceutical worth $57.4K as of Q2 2026.
  • Pinnacle Bancorp bought 2,388 Takeda Pharmaceutical shares in Q2 2026, an estimated $39.5K.
  • Takeda Pharmaceutical made up 0.01% of Pinnacle Bancorp's portfolio in Q2 2026, its #439 holding.
  • Pinnacle Bancorp first reported a position in Takeda Pharmaceutical in Q1 2019 and has held it in 30 quarters since.
  • 376 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q2 2026.

Based on Pinnacle Bancorp's 13F filing for Q2 2026, filed 28 Jul 2026.